Asymptomatic diclofenac-induced acute hepatitis;Asymptomatische diclofenac-induzierte akute hepatitis

Deutsche Medizinische Wochenschrift

Volumn 125, Issue 25-26, 2000, Pages 797-800

  Dierkes Globisch, A ^a   Schafer R ^b   Mohr, H H ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DICLOFENAC; FLUPIRTINE;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; CHOLESTASIS; CLINICAL FEATURE; DRUG WITHDRAWAL; HUMAN; JAUNDICE; LOW BACK PAIN; MALE; TOXIC HEPATITIS;

EID: 0034705515     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024521     Document Type: Article

References (20)

1. 1 Babany, G., J. Bernuau, G. Danan, B. Rueff, J.-P. Benhamou: Fulminating hepatitis in a woman taking glafenine and diclofenac. Gastroenterol. clin. biol. 9 (1985), 185.
2. 2 Breen, E. G., J. McNicholl, E. Cosgrove, J. McCabe, F. M. Stevens: Fatal hepatitis associated with diclofenac. Gut 27 (1986), 1390-1393.
3. 3 Catalane, M. A.: Worldwide safety experience with diclofenac. Amer. J. Med. 80 Suppl 4 B (1986), 81-87.
4. 4 Desmet, V. J., M. Gerber, J. H. Hoofnagle, M. P. Manns, P. J. Scheuer: Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19 (1994), 1513-1520.
5. 5 Dunk, A. A., R. P. Walt, W. J. Jenkins, S. S. Sherlock: Diclofenac hepatitis. Brit. med. J. 284 (1982), 1605-1606.
6. 6 Friedel, H. A., A. Fitton: Flupirtine - a review of its pharmacological properties, and therapeutic efficacy in pain states. Drugs 45 (1993), 548-569.
7. 7 Gil, M. L., M. C. Ramirez, M. C. Terencio, J. V. Castell: Immunochemical detection of protein adducts in cultured human hepatocytes exposed to diclofenac. Biochimic. biophysic. Acta 1272 (1995), 140-146.
8. 8 Iveson, T. J., N. G. Ryley, P. M. A. Kelley, J. M. Trowell, J. O. D. McGee, R. W. G. Chapman: Diclofenac associated hepatitis. J. Hepatol. 10 (1990), 85-89.
9. 9 Mazeika, P. K., M. J. Ford: Chronic active hepatitis associated with diclofenac sodium therapy. Br. J. clin. Pract. 43 (1989), 125-126.
10. 10 Ohana, M., K. Hajiro, H. Takakuwa, K. Okazaki: Recovery from diclofenac-induced hypersensitive fulminant hepatitis and prostaglandins. Dig. Dis. Sci. 42 (1997), 2031-2032.
11. 11 Ouellette, G. S., B. E. Slitzky, J. A. Gates, S. Lagarde, A. B. West: Reversible hepatitis associated with diclofenac. J. Clin. Gastroenterol. 13 (2) (1991), 205-210.
12. 12 Purcell, P., D. Henry, G. Melville: Diclofenac hepatitis. Gut 32 (1991), 1381-1385.
13. 13 Rabinovitz, M., D. H. Van Thiel: Hepatotoxicity of nonsteroidal anti-inflammatory drugs. Amer. J. Gastroenterol. 87 (1992), 1696-1704.
14. 14 Ramakrishna, B., N. Viswanath: Diclofenac-induced hepatitis: Case report and literature review. Liver 14 (1994), 83-84.
15. 15 Rodriguez, L. A. G., R. Williams, L. E. Derby, A. D. Dean, H. Jick: Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. Arch. Intern. Med. 154 (1994), 311-316.
16. 16 Sallie, R. W., T. McKenzie, W. D. Reed, M. F. Quinlan, K. B. Shilkin: Diclofenac hepatitis. Aust. N. Z. J. Med. 21 (1991), 251-255.
17. 17 Schmitz, G., I. Stauffert, H. Seppel, H. Lepper, C. J. Estler: Toxicity of diclofenac to isolated hepatocytes. J. Hepatol. 14 (1992), 408-409.
18. 18 Scully, L. J., D. Clarke, R. J. Barr: Diclofenac induced hepatitis. Dig. Dis. Sci. 38 (1993), 744-751.
19. 19 Seidl, C., R. Thomsen, A. Lohse, V. Grouls: Phenprocoumon-assoziierte Hepatitis - eine seltene Nebenwirkung der oralen Antikoagulation. Leber Magen Darm 28 (1998), 178-182.
20. 20 Zimmermann, H. J., W. C. Madrey: Toxic and drug induced hepatitis. In: Schiff, L., E. R. Schiff (eds.): Disease of the liver. 6. Aufl., Philadelphia, J. B. Lippincott (1987), 591-668.